3Spine Announces Completion of FDA Clinical Trial Enrollment Achieving 325 Surgeries in 2023
January 10, 2024
3Spine’s MOTUS device is a ‘first-of-kind’ breakthrough medical technology indicated for the biomechanical reconstruction and stabilization of a spinal motion segment
